CME Group
CME · Financial Exchanges & Data
$305.71
0.1%FactSet
FDS · Financial Exchanges & Data
$331.32
1.2%The short version
- CME Group is the larger business, with $6.5B of revenue in fiscal 2025 against $2.5B for FactSet, about 2.6 times as much.
- CME Group kept more of each dollar of sales as operating profit (64.9% operating margin, against 28.3% operating margin).
- CME Group turned more of its sales into free cash flow (64.3% FCF margin, against 28.6% FCF margin).
- FactSet earned a higher return on the capital invested in it (18.2%, against 11.9%).
- Investors pay more for each dollar of CME Group’s earnings: a P/E of 25.1x against 22.7x for FactSet.
| Latest fiscal year | CME · FY25 | FDS · FY26 |
|---|---|---|
| Size | ||
| Market cap | $109.6B | $12.1B |
| Revenue | $6.5B | $2.5B |
| Free cash flow | $4.2B | $707M |
| Net income | $4.1B | $534M |
| Growth | ||
| Revenue growth | 6.4% | 6.7% |
| 5-year growth | 6.0% | 9.3% |
| Share count change | 0.1% | −4.6% |
| Profitability | ||
| Gross margin | — | 50.6% |
| Operating margin | 64.9% | 28.3% |
| Net margin | 62.5% | 21.5% |
| FCF margin | 64.3% | 28.6% |
| Return on capital | 11.9% | 18.2% |
| Return on equity | 14.8% | 25.5% |
| Balance sheet | ||
| Net debt | −$1.1B | $1.1B |
| Net debt / EBITDA | −0.3x | 1.3x |
| Dividends and buybacks | $3.9B | $808M |
| Valuation & quality | ||
| P/E | 25.1x | 22.7x |
| Piotroski F-score | 7 | 6 |
FY17
CME $3.6B
FDS $1.2B
FY18
CME $4.3B
FDS $1.4B
FY19
CME $4.9B
FDS $1.4B
FY20
CME $4.9B
FDS $1.5B
FY21
CME $4.7B
FDS $1.6B
FY22
CME $5.0B
FDS $1.8B
FY23
CME $5.6B
FDS $2.1B
FY24
CME $6.1B
FDS $2.2B
FY25
CME $6.5B
FDS $2.3B
FY26
CME —
FDS $2.5B
CME
FDS
FY17
CME 63.4%
FDS 28.8%
FY18
CME 60.5%
FDS 27.1%
FY19
CME 53.2%
FDS 30.5%
FY20
CME 54.0%
FDS 29.4%
FY21
CME 56.4%
FDS 29.8%
FY22
CME 60.1%
FDS 25.8%
FY23
CME 61.6%
FDS 30.2%
FY24
CME 64.1%
FDS 31.8%
FY25
CME 64.9%
FDS 32.2%
FY26
CME —
FDS 28.3%
CME
FDS
FY17
CME $1.7B
FDS $284M
FY18
CME $2.3B
FDS $352M
FY19
CME $2.4B
FDS $368M
FY20
CME $2.5B
FDS $428M
FY21
CME $2.3B
FDS $494M
FY22
CME $3.0B
FDS $487M
FY23
CME $3.4B
FDS $585M
FY24
CME $3.6B
FDS $615M
FY25
CME $4.2B
FDS $617M
FY26
CME —
FDS $707M
CME
FDS
FY17
CME 10.7%
FDS 35.9%
FY18
CME 7.2%
FDS 31.4%
FY19
CME 7.1%
FDS 42.5%
FY20
CME 7.2%
FDS 44.5%
FY21
CME 7.3%
FDS 46.6%
FY22
CME 8.3%
FDS 23.3%
FY23
CME 9.8%
FDS 18.2%
FY24
CME 11.3%
FDS 20.8%
FY25
CME 11.9%
FDS 20.7%
FY26
CME —
FDS 18.2%
CME
FDS
Add another company
Compare up to four at once.
Each company's latest fiscal year; fiscal years end in different months. The best value in each row is highlighted where higher (or lower) is clearly better. Not investment advice.